arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Azitra, Inc.

AZTR
$0.13 0.00 (-0.44%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
5 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

Azitra, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth N/M
Op. Margin
ROIC -288.7%
FCF / Share $-2.31
Trailing P/E
Price / Book 0.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

5-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-10.96M
↓ -22.2%
FCF / Share Free cash flow per share
$-2.31
↑ +87.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
0
Cash Quality
67

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 18 quarters